UNSPSC 51401507: Bretazenil

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51401507

Definition

This classification denotes an anxiolytic and anticonvulsant agent with the molecular formula C19H20BrN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OSZ0E9DGOJ, chemically known as 9h-imidazo(1,5-a)pyrrolo(2,1-c)(1,4)benzodiazepine-1-carboxylic acid, 8-bromo-11,12,13,13a-tetrahydro-9-oxo-, 1,1-dimethylethyl ester, (s)- but generally known as bretazenil, which bears US NIH Compound Identifier 107926.

Read the full definition

European Medicines Agency schedules Bretazenil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05886MIG. The term BRETAZENIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). BRETAZENIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bretazenil under HS 29339940 and SITC 51577. As of Q4 2014, BRETAZENIL remains the US FDA Preferred Term for this commodity.

Bretazenil bears US NLM identifiers UMLS ID C0073482 and NCI Concept Code C72111. SMILES: BRC1C2C(=O)N3C(CCC3)C3N(C2CCC1)CNC3C(=O)OC(C)(C)C.

About UNSPSC 51401507

UNSPSC 51401507 Bretazenil is a Commodity code that in recent state and local solicitations captures procurement of naloxone and drug deactivation systems for public health and emergency response purposes. State and local health departments and county public-health agencies are the primary issuing bodies soliciting under this code, though the single recent opportunity reflects activity within regional health systems rather than a broad cross-sector buyer base. The scope of work centers on the acquisition of naloxone units and safe drug deactivation systems for community health initiatives, with vendors expected to manage delivery, logistics, and compliance with federal and state workplace requirements including E-Verify verification and drug-free workplace certification. Contracts typically carry fixed-fee pricing structures, multi-year initial terms with renewal options, and probationary periods allowing termination without cause.

Recent activity concentrates in Florida. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford; the IFB response deadline was July 26, 2023, and the procurement included FEMA funding considerations alongside standard commercial general liability and workers' compensation insurance requirements. The code shows limited recent state and local solicitation volume overall; apart from the Seminole County opportunity, no other recent postings appear in the available source material.

Quick answers

What is UNSPSC 51401507?

UNSPSC 51401507 is Bretazenil, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51401507?

UNSPSC 51401507 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51401507

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code